Yan Wu

US Patent:

20090254924, Oct 8, 2009

Filed:

Apr 4, 2008

Appl. No.:

12/098161

Inventors:

Ani Anirudh - Redmond WA, US
Anirban Banerjee - Issaquah WA, US
Christopher D. Gual - Seattle WA, US
Deyun Wu - Issaquah WA, US
Hui Shen - Sammamish WA, US
John W. Archer - Marysville WA, US
Michael Bell - Auburn WA, US
Mitesh K. Desai - Redmond WA, US
Saurabh Mahajan - Redmond WA, US
Senthilkumar Veluswami - Bellevue WA, US
Xiong Jiang - Lynnwood WA, US
Sundar P. Subramani - Bellevue WA, US
Taroon Mandhana - Redmond WA, US
Thomas W. Kuehnel - Seattle WA, US
Yan Wu - Redmond WA, US
Yi Lu - Sammamish WA, US
David A. Roberts - Redmond WA, US

Assignee:

Microsoft Corporation - Redmond WA

International Classification:

G06F 3/00

US Classification:

719321

Abstract:

Some embodiments of the invention provide an interface between programmed instructions (e.g., an operating system) and a miniport driver configured to communicate with radio hardware on a computer. The interface may include components operable to invoke various wireless connectivity-related functionality implemented by the radio hardware and/or miniport driver. The functionality may, for example, include a capability whereby the computer may maintain simultaneous connections on a plurality of wireless networks using a single radio, and/or a capability whereby the computer may function as an access point for a wireless network.

US Patent:

20230113802, Apr 13, 2023

Filed:

Feb 25, 2021

Appl. No.:

17/904907

Inventors:

- Seattle WA, US
James Griffin - Seattle WA, US
Qingxin Mu - Seattle WA, US
Yan Wu - Seattle WA, US
Jesse Yu - Seattle WA, US

Assignee:

University of Washington - Seattle WA

International Classification:

A61K 31/7068
A61K 9/00
A61K 31/337
A61K 31/635
A61K 31/519
A61K 47/24
A61P 35/00
A61P 35/04

Abstract:

The present disclosure describes an injectable aqueous dispersion, including an aqueous solvent, and a chemotherapeutic agent composition dispersed in the aqueous solvent to provide the injectable aqueous dispersion. The chemotherapeutic agent composition includes a combination of chemotherapeutic agents selected from: gemcitabine and paclitaxel; and venetoclax and zanubrutinib. The chemotherapeutic agent composition further includes one or more compatibilizers comprising a lipid (e.g., a lipid excipient), a lipid conjugate, or a combination thereof. The chemotherapeutic agents of the chemotherapeutic agent composition exhibit a synergistic chemotherapeutic effect.

US Patent:

20150303453, Oct 22, 2015

Filed:

Aug 8, 2012

Appl. No.:

14/420198

Inventors:

Jihui YANG - Bellevue WA, US
Yan WU - Troy MI, US
Yong YANG - Xiamen, Fujian, CN
Sihui WANG - Xiamen, Fujian, CN

International Classification:

H01M 4/36
H01M 4/505
H01M 4/525
H01M 10/0525

Abstract:

Composite materials for a cathode of an electrochemical cell. The composite materials comprise Li[M1−xLix]O2 or yLi2MnO3.(1−y)LiMO2(M=Ni, Co, Mn, 0